It is labeled as "1. MLCL/CL ratio", defined as: "2. A diagnostic measurement of the ratio of monolysocardiolipin (MLCL) to cardiolipin (CL) in blood spots, used as a functional assay to identify Barth syndrome by assessing mitochondrial phospholipid remodeling.", and related terms include "mitochondrial phospholipid remodeling".